Regional Variation in Total Cost per Radical Prostatectomy in the Healthcare Cost and Utilization Project Nationwide Inpatient Sample Database

Journal of Urology

Volumn 183, Issue 4, 2010, Pages 1504-1509

  Makarov, Danil V ^a,b   Loeb, Stacy ^c   Landman, Adam B ^a,b   Nielsen, Matthew E ^d   Gross, Cary P ^a   Leslie, Douglas L ^e   Penson, David F ^f   Desai, Rani A ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^c DEPARTMENT OF PATHOLOGY   (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^e MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^f VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

costs and cost analysis; health policy; prostatectomy; prostatic neoplasms; small area analysis

Indexed keywords

ACCOUNTING; ADULT; ARTICLE; CLINICAL TRIAL; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; CYSTECTOMY; DEMOGRAPHY; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH CARE UTILIZATION; HOSPITAL COST; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; SURGICAL TECHNIQUE; TREATMENT OUTCOME; UNITED STATES;

COSTS AND COST ANALYSIS; DATABASES, FACTUAL; HEALTH CARE COSTS; HUMANS; MALE; MIDDLE AGED; PROSTATECTOMY; PROSTATIC NEOPLASMS; UNITED STATES;

EID: 77949284294     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2009.12.014     Document Type: Article

References (29)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2008. CA Cancer J Clin 58 (2008) 71
2. Brown M.L. The Economic Burden of Cancer (2005), Marcel Dekker, New York
3. Optenberg S.A., and Thompson I.M. Economics of screening for carcinoma of the prostate. Urol Clin North Am 17 (1990) 719
4. Saigal C.S., and Litwin M.S. The economic costs of early stage prostate cancer. Pharmacoeconomics 20 (2002) 869
5. Penson D.F., and Chan J.M. Prostate cancer. J Urol 177 (2007) 2020
6. Holmberg L., Bill-Axelson A., Helgesen F., et al. A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. N Engl J Med 347 (2002) 781
7. Bill-Axelson A., Holmberg L., Ruutu M., et al. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 352 (2005) 1977
8. Bill-Axelson A., Holmberg L., Filen F., et al. Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian Prostate Cancer Group-4 randomized trial. J Natl Cancer Inst 100 (2008) 1144
9. Albertsen P.C., Hanley J.A., Penson D.F., et al. 13-Year outcomes following treatment for clinically localized prostate cancer in a population based cohort. J Urol 177 (2007) 932
10. Penson D.F., McLerran D., Feng Z., et al. 5-Year urinary and sexual outcomes after radical prostatectomy: results from the Prostate Cancer Outcomes Study. J Urol 179 (2008) S40
11. Wennberg J., and Gittelsohn A. Small area variations in health care delivery. Science 182 (1973) 1102
12. Birkmeyer J.D., Sharp S.M., Finlayson S.R., et al. Variation profiles of common surgical procedures. Surgery 124 (1998) 917
13. Lu-Yao G.L., McLerran D., Wasson J., et al. An assessment of radical prostatectomy. Time trends, geographic variation, and outcomes. The Prostate Patient Outcomes Research Team. JAMA 269 (1993) 2633
14. Greenwald H.P., and Henke C.J. HMO membership, treatment, and mortality risk among prostatic cancer patients. Am J Public Health 82 (1992) 1099
15. Manning W.G., Newhouse J.P., Duan N., et al. Health insurance and the demand for medical care: evidence from a randomized experiment. Am Econ Rev 77 (1987) 251
16. McGuire T.G. Physician agency. In: Culyer A.J., and Newhouse J.P. (Eds). Handbook of Health Economics (2000), Elsevier, New York
17. Johnson-Lans S. A Health Economics Primer (2006), Person/Addison Wesley, Boston
18. Friedman B., Jiang H.J., Elixhauser A., et al. Hospital inpatient costs for adults with multiple chronic conditions. Med Care Res Rev 63 (2006) 327
19. Elixhauser A., Steiner C., Harris D.R., et al. Comorbidity measures for use with administrative data. Med Care 36 (1998) 8
20. Duan N. Smearing estimate: a nonparametric retransformation method. J Am Stat Assoc 78 (1983) 605
21. Census 2000: State and State Equivalent Areas in ArcView Shapefile (.shp) Format (2009), United States Census Bureau, Washington, D. C
22. Lu-Yao G.L., Potosky A.L., Albertsen P.C., et al. Follow-up prostate cancer treatments after radical prostatectomy: a population-based study. J Natl Cancer Inst 88 (1996) 166
23. O'Neill L., and Kuder J. Explaining variation in physician practice patterns and their propensities to recommend services. Med Care Res Rev 62 (2005) 339
24. Sirovich B., Gallagher P.M., Wennberg D.E., et al. Discretionary decision making by primary care physicians and the cost of U. S. health care. Health Aff (Millwood) 27 (2008) 813
25. Nallamothu B.K., Rogers M.A., Chernew M.E., et al. Opening of specialty cardiac hospitals and use of coronary revascularization in Medicare beneficiaries. JAMA 297 (2007) 962
26. Benko L.B. On the lookout. CMS studies outlier billing practices. Mod Healthcare 32 (2002) 14
27. Watcha M.F., and White P.F. Economics of anesthetic practice. Anesthesiology 86 (1997) 1170
28. Cooper R.A. States with more health care spending have better-quality health care: lessons about Medicare. Health Aff (Millwood) 28 (2009) w103
29. Finkler S.A. The distinction between cost and charges. Ann Intern Med 96 (1982) 102